GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $3.29 Thursday, 18th Apr 2024 ABUS stock ended at $2.73. This is 1.80% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.72% from a day low at $2.69 to a day high of $2.79.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2024-03-13 $2.70 $2.74 $2.67 $2.70 684 399
2024-03-12 $2.73 $2.75 $2.69 $2.69 425 035
2024-03-11 $2.71 $2.79 $2.71 $2.72 557 448
2024-03-08 $2.74 $2.79 $2.71 $2.73 461 406
2024-03-07 $2.73 $2.76 $2.69 $2.70 394 386
2024-03-06 $2.61 $2.75 $2.60 $2.74 734 825
2024-03-05 $2.68 $2.73 $2.66 $2.67 618 134
2024-03-04 $2.78 $2.78 $2.70 $2.71 534 629
2024-03-01 $2.74 $2.81 $2.74 $2.79 914 761
2024-02-29 $2.87 $2.87 $2.72 $2.80 1 057 027
2024-02-28 $2.88 $2.92 $2.85 $2.88 698 084
2024-02-27 $2.94 $2.96 $2.88 $2.92 886 335
2024-02-26 $2.91 $2.95 $2.89 $2.92 607 852
2024-02-23 $2.91 $2.94 $2.90 $2.92 821 560
2024-02-22 $2.87 $2.96 $2.87 $2.91 798 101
2024-02-21 $2.87 $2.90 $2.84 $2.88 991 200
2024-02-20 $2.89 $2.94 $2.86 $2.88 1 162 323
2024-02-16 $2.91 $2.95 $2.88 $2.90 1 474 553
2024-02-15 $2.95 $2.95 $2.86 $2.91 1 874 563
2024-02-14 $2.91 $2.94 $2.88 $2.91 1 486 742
2024-02-13 $2.76 $2.91 $2.76 $2.89 2 672 196
2024-02-12 $2.78 $2.88 $2.76 $2.87 2 141 773
2024-02-09 $2.57 $2.79 $2.56 $2.76 3 807 120
2024-02-08 $2.56 $2.65 $2.34 $2.54 4 006 797
2024-02-07 $2.46 $2.53 $2.39 $2.49 1 474 992
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT